Stage IIIC Prostate Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for Daratumumab (DB09331)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8) | Active Not Recruiting | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03177460 | Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer | Treatment |